70.50
Inspire Medical Systems Inc stock is traded at $70.50, with a volume of 609.84K.
It is up +2.46% in the last 24 hours and up +15.44% over the past month.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
See More
Previous Close:
$68.81
Open:
$68.65
24h Volume:
609.84K
Relative Volume:
0.70
Market Cap:
$2.04B
Revenue:
$915.25M
Net Income/Loss:
$131.14M
P/E Ratio:
15.76
EPS:
4.472
Net Cash Flow:
$96.71M
1W Performance:
-8.18%
1M Performance:
+15.44%
6M Performance:
+37.13%
1Y Performance:
-8.82%
Inspire Medical Systems Inc Stock (INSP) Company Profile
Name
Inspire Medical Systems Inc
Sector
Industry
Phone
763-957-5037
Address
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
INSP
Inspire Medical Systems Inc
|
70.50 | 2.04B | 915.25M | 131.14M | 96.71M | 4.472 |
|
ABT
Abbott Laboratories
|
101.29 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
88.64 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
272.36 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
43.92 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.29 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-12-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-12-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-22-26 | Downgrade | Truist | Buy → Hold |
| Dec-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-02-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-26-25 | Upgrade | Truist | Hold → Buy |
| Nov-25-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-24-25 | Upgrade | Stifel | Hold → Buy |
| Nov-04-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-24-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-25 | Downgrade | UBS | Buy → Neutral |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Aug-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Aug-05-25 | Downgrade | Truist | Buy → Hold |
| Nov-20-24 | Upgrade | BofA Securities | Neutral → Buy |
| May-08-24 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-19-24 | Initiated | Morgan Stanley | Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Jan-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-13-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Nov-03-20 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-03-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Sep-22-20 | Initiated | JP Morgan | Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-15-20 | Initiated | Goldman | Buy |
| Jun-18-20 | Reiterated | Piper Sandler | Overweight |
| May-18-20 | Initiated | Lake Street | Buy |
| Apr-28-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-09-20 | Initiated | Piper Sandler | Overweight |
| Jan-28-20 | Initiated | Oppenheimer | Underperform |
| Jan-27-20 | Initiated | Oppenheimer | Underperform |
| Nov-06-19 | Upgrade | Berenberg | Sell → Hold |
| Feb-05-19 | Initiated | Dougherty & Company | Buy |
| Nov-28-18 | Initiated | Berenberg | Sell |
| Oct-29-18 | Initiated | Leerink Partners | Outperform |
| May-29-18 | Initiated | Guggenheim | Buy |
| May-29-18 | Initiated | Stifel | Buy |
| May-29-18 | Initiated | Wells Fargo | Outperform |
View All
Inspire Medical Systems Inc Stock (INSP) Latest News
Top Inspire Medical Systems (INSP) Competitors 2026 - MarketBeat
Inspire Medical Systems, Inc. (INSP) Stock Price, News, Quote & History - Yahoo! Finance Canada
100th patient in the UK receives Inspire therapy implant - Manchester University NHS Foundation Trust
Inspire Medical Systems Inc (INSP) Shares Fall 3.1% -- What GF S - GuruFocus
Inspire Medical Systems, Inc. (INSP) Latest Stock News & HeadlinesYahoo Finance - ca.finance.yahoo.com
Inspire Medical Systems, Inc. (INSP) latest stock news and headlines - Yahoo Finance UK
Inspire Medical Systems, Inc. (INSP) latest stock news and headlines – Yahoo Finance - Yahoo Finance Singapore
Inspire Medical Systems, Inc. (INSP) Stock Forecasts - Yahoo Finance
Here's Why You Should Retain INSP Stock in Your Portfolio for Now - Zacks Investment Research
Here's Why You Should Retain INSP Stock in Your Portfolio for Now - Zacks Investment Research
Inspire Medical Systems, Inc. (INSP) stock price, news, quote and historyYahoo Finance - sg.finance.yahoo.com
Inspire Medical Systems Drops 5.2% After Freedom Capital Markets Maintains Buy - AlphaStreet
ETFs Investing in Inspire Medical Systems, Inc. Stocks - TradingView
(INSP) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Microsoft To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Monday - benzinga.com
Freedom Capital Markets maintains Buy rating on Inspire Medical Systems, $97 price target - TradingView
Freedom Capital Markets Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Raises Target Price to $97 - Moomoo
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating the Challenges of Growth in the Medical Devices Sector - DirectorsTalk Interviews
Is It Too Late to Buy Inspire Medical Systems Inc (INSP) After 5 - GuruFocus
Inspire Medical Systems (INSP) And The Valuation Debate Following Its Inspire V Delay - simplywall.st
Inspire Medical Systems, Inc. Common Stock (NYSE:INSP) Price Chart - The Chronicle-Journal
Inspire Medical Systems (INSP) Stock Could Be 14% Undervalued On Cash Flow - Yahoo Finance
Zacks Industry Outlook Medical Systems, American Well and Butterfly Network - TradingView
Inspire Medical Systems INSP Jumps After Stifel Price Target Hike - StocksToTrade
InvestingPro’s Fair Value spotted 65% gain in Inspire Medical stock By Investing.com - Investing.com Australia
Why Inspire Medical Systems (INSP) Stock Is Up Today - Yahoo Finance
Inspire Medical Systems Inc (INSP) Stock Up 7.2% and Still Under - GuruFocus
Inspire Medical Systems Inc (INSP) Stock Up 7.2% and Still Undervalued -- GF Score: 58/100 - GuruFocus
INSP Maintains by Stifel -- Price Target Raised to $80.00 - GuruFocus
Inspire Medical Systems Jumps 8.7% Amid Sector-Wide Rally - AlphaStreet
Price-Driven Insight from (INSP) for Rule-Based Strategy - news.stocktradersdaily.com
Stifel raises Inspire Medical stock price target on reimbursement outlook By Investing.com - Investing.com India
Inspire Medical at Wells Fargo conference: growth reset takes shape By Investing.com - Investing.com South Africa
Top 3 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
Inspire Medical at Wells Fargo conference: growth reset takes shape - Investing.com
INSP: Coding clarity, Inspire V outcomes, and Project Horizon set stage for renewed growth - TradingView
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Growth Potential with a 17.97% Return on Equity - DirectorsTalk Interviews
Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Inspire Medical (INSP) awards 6,350 RSUs vesting over 3 years - Stock Titan
Inspire Medical Systems | 4: Statement of changes in beneficial ownership of securities - Moomoo
Inspire Medical Systems Inc Stock (INSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):